These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34390530)

  • 1. Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
    Siegbahn A; Lindbäck J; Hijazi Z; Åberg M; Alexander JH; Eikelboom JW; Lopes RD; Pol T; Oldgren J; Granger CB; Yusuf S; Wallentin L
    J Thromb Haemost; 2021 Nov; 19(11):2726-2737. PubMed ID: 34390530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Pol T; Hijazi Z; Lindbäck J; Oldgren J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Siegbahn A; Wallentin L
    Cardiovasc Res; 2022 Jul; 118(9):2112-2123. PubMed ID: 34358298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
    Hijazi Z; Wallentin L; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Pol T; Yusuf S; Oldgren J; Siegbahn A
    J Am Heart Assoc; 2020 Dec; 9(24):e018984. PubMed ID: 33292046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
    Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Alings M; De Caterina R; Eikelboom JW; Ezekowitz MD; Held C; Huber K; Hylek EM; Granger CB; Lopes RD; Vinereanu D; Siegbahn A; Wallentin L
    JAMA Netw Open; 2020 Sep; 3(9):e2015943. PubMed ID: 32936298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (
    Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Granger CB; Wallentin L;
    Lancet; 2016 Jun; 387(10035):2302-2311. PubMed ID: 27056738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
    Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
    Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Hijazi Z; Aulin J; Andersson U; Alexander JH; Gersh B; Granger CB; Hanna M; Horowitz J; Hylek EM; Lopes RD; Siegbahn A; Wallentin L;
    Heart; 2016 Apr; 102(7):508-17. PubMed ID: 26839066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark.
    Karasoy D; Gislason GH; Hansen J; Johannessen A; Køber L; Hvidtfeldt M; Özcan C; Torp-Pedersen C; Hansen ML
    Eur Heart J; 2015 Feb; 36(5):307-14a. PubMed ID: 25368205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of oral anticoagulation among octogenarians with atrial fibrillation and anaemia.
    Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Golino P; Russo V
    J Thromb Thrombolysis; 2023 Feb; 55(2):222-227. PubMed ID: 36472719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
    Aulin J; Hijazi Z; Siegbahn A; Andersson U; Alexander JH; Connolly SJ; Ezekowitz MD; Gersh BJ; Granger CB; Horowitz J; Hylek EM; Lopes RD; Yusuf S; Wallentin L; Oldgren J
    J Thromb Haemost; 2020 Sep; 18(9):2287-2295. PubMed ID: 32510737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.
    Pol T; Held C; Westerbergh J; Lindbäck J; Alexander JH; Alings M; Erol C; Goto S; Halvorsen S; Huber K; Hanna M; Lopes RD; Ruzyllo W; Granger CB; Hijazi Z
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29419390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
    Pol T; Hijazi Z; Lindbäck J; Alexander JH; Bahit MC; De Caterina R; Eikelboom JW; Ezekowitz MD; Gersh BJ; Granger CB; Hylek EM; Lopes R; Siegbahn A; Wallentin L
    Open Heart; 2021 Mar; 8(1):. PubMed ID: 33741689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.